Genova Biotherapeutics Inc. 5
5 · Genova Biotherapeutics Inc. · Filed Sep 17, 2009
Insider Transaction Report
Form 5
Global Developments Inc.
10% Owner
Transactions
- Other
Common
2009-07-13+110,980,000→ 111,875,000 total - Sale
Common
2009-09-10$183219.00/sh−895,500$164,072,614,500→ 110,979,500 total - Sale
Common
2009-09-11$409526.00/sh−1,479,500$605,893,717,000→ 109,500,000 total - Purchase
Common
2007-03-07$32500.00/sh+650,000$21,125,000,000→ 650,000 total - Sale
Common
2007-12-31$2375.00/sh−5,000$11,875,000→ 645,000 total - Other
Common
2009-04-20+250,000→ 895,000 total
Footnotes (2)
- [F1]The Reporting Person is holding the shares in escrow pursuant to an asset purchase agreement between the Issuer and Phoinis Oxford Lifescience Limited dated April 15, 2009. The Reporting Person has voitng and dispositive rights to these shares until released from escrow pursuant to the terms of an escrow agreement.
- [F2]Net effects of a 125-for-1 forward stock split effective July 13, 2009.